Yang C.-W.MING YAOYA-CHIEN YANGCHIA-YU CHU2019-12-042019-12-0420171027-8117https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015441589&doi=10.1016%2fj.dsi.2017.01.001&partnerID=40&md5=5436bc6ed18e446b964d20a84b928c82https://scholars.lib.ntu.edu.tw/handle/123456789/434876[SDGs]SDG3alpha interferon; carmustine; CD3 antigen; CD4 antigen; CD56 antigen; CD8 antigen; cisplatin; cyclophosphamide; doxorubicin; etoposide; Human T cell leukemia virus antibody; interleukin 2 receptor alpha; methylprednisolone; prednisolone; vinblastine; vincristine; virus DNA; zidovudine; adult; back; buttock; cancer combination chemotherapy; case report; clinical article; clinical feature; computer assisted tomography; corticosteroid therapy; disease severity; drug pulse therapy; eosinophil; erythrocyte; extravasation; female; granulomatous vasculitis; histopathology; human; Human T-lymphotropic virus 1; human tissue; immunocompromised patient; immunohistochemistry; immunophenotyping; labia minora; Letter; leukemia remission; leukocyte count; lung aspergillosis; lymphadenopathy; lymphocyte; lymphocytosis; maxillary sinus; medical history; middle aged; nose cavity; physical examination; polymerase chain reaction; pruritus; rash; recurrent infection; second toe; skin biopsy; skin necrosis; skin ulcer; T cell leukemia; urosepsis; Wegener granulomatosisletter10.1016/j.dsi.2017.01.0012-s2.0-85015441589